Skip to content

Genetic causes of congenital whole globe abnormalities in India

Microphthalmia, anophthalmia, coloboma (MAC) and retinoic acid pathway genes - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107692
Enrollment
200
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Department of Biotechnology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with Microphthalmos, Anophthalmos, and coloboma (MAC) Prioritize patients with bilateral MAC, multiple affected family members and/or consanguineous parents, and patients who have undergone prior genetic testing with Exome Sequencing or gene panels that were non-diagnostic to increase the chance of identifying causative genetic variant(s) with whole genome sequencing.

Exclusion criteria

Exclusion criteria: Posterior microphthalmos or nanophthalmos that are anatomically and genetically distinct forms of microphthalmia Patients with environmental exposures (other than Vitamin A Deficiency) as the cause for MAC

Design outcomes

Primary

MeasureTime frame
Phenotype and genotype of 400 MAC patients with unique differences in the clinical and genetic profile of patients in India and USATimepoint: 2 years

Secondary

MeasureTime frame
Genotype-phenotype correlation, especially for Retinoic Acid pathway genesTimepoint: 2 years;Identification of new genesTimepoint: 2 years

Countries

India

Contacts

Public ContactDr Shailja Tibrewal

Dr Shroff Charity Eye Hospital

shailja1408@gmail.com09971610491

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026